Q4 2015 Holdings
Filed 2016-02-16 | 109 holdings | $78.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $30.3M | 377,188 | 38.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $19.7M | 946,022 | 25.3% |
| Axogen Inc(AXGN) | COM | 05463X106 | $16.9M | 3,381,439 | 21.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $4.7M | 690,538 | 6.0% |
| Acura Pharmaceuticals Inc(ACUR) | COM PAR $0.01 | 00509L802 | $2.6M | 1,025,641 | 3.3% |
| Caredx Inc(CDNA) | COM | 14167L103 | $1.5M | 229,000 | 1.9% |
| Horizon Pharma PLC | SHS | G4617B105 | $253.2K | 11,684,801 | 0.3% |
| Nxstage Medical Inc | COM | 67072V103 | $100.5K | 4,589,000 | 0.1% |
| Dyax Corp | COM | 26746E103 | $84.3K | 2,242,073 | 0.1% |
| Adeptus Health Inc(ADPTEUR) | CL A | 006855100 | $71.3K | 1,307,908 | 0.1% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $67.6K | 1,675,385 | 0.1% |
| Aetna Inc New | COM | 00817Y108 | $63.9K | 591,465 | 0.1% |
| Davita Healthcare Partners I(DVA) | COM | 23918K108 | $57.3K | 822,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $57.1K | 1,056,000 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $55.8K | 5,996,691 | 0.1% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $53.8K | 532,000 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $53.5K | 815,000 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $49.7K | 4,072,809 | 0.1% |
| Healthways Inc | NOTE 1.500% 7/0 | 422245AB6 | $49.1K | $51,925,000 | 0.1% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $42.3K | $45,000,000 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $37.6K | 1,163,811 | 0.0% |
| Heartware Intl Inc | NOTE 3.500%12/1 | 422368AA8 | $37.4K | $39,226,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $36.8K | 8,729,361 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | ADR | 881624209 | $36.1K | 550,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $35.2K | 683,749 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $34.9K | 598,854 | 0.0% |
| Endologix Inc | NOTE 2.250%12/1 | 29266SAA4 | $34.6K | $40,941,000 | 0.0% |
| Xenoport Inc | COM | 98411C100 | $34.5K | 6,287,374 | 0.0% |
| AAC Hldgs Inc(AACH) | COM | 000307108 | $34.0K | 1,782,094 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $33.8K | 4,305,288 | 0.0% |
| Universal Amern Corp New | COM | 91338E101 | $33.5K | 4,789,027 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $32.9K | 386,457 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $32.6K | 3,264,588 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $32.5K | $30,000,000 | 0.0% |
| Healthways Inc | COM | 422245100 | $31.7K | 2,465,042 | 0.0% |
| Accuray Inc | NOTE 3.750% 8/0 | 004397AB1 | $30.9K | $30,511,000 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $28.9K | 3,732,412 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $28.5K | 144,646 | 0.0% |
| Genomic Health Inc(GHDX) | COM | 37244C101 | $28.5K | 809,432 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $28.5K | 371,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $28.2K | 680,000 | 0.0% |
| Kempharm Inc | COM | 488445107 | $28.2K | 1,420,497 | 0.0% |
| Pronai Therapeutics Inc | COM | 74346L101 | $26.9K | 1,791,255 | 0.0% |
| Relypsa Inc | COM | 759531106 | $25.5K | 900,281 | 0.0% |
| Spectranetics Corp | MTNF 2.625% 6/0 | 84760CAA5 | $22.5K | $29,831,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $21.5K | 310,122 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $19.7K | 807,875 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $19.6K | 1,265,343 | 0.0% |
| Rite AID Corp | COM | 767754104 | $19.5K | 2,492,772 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $19.4K | 1,169,042 | 0.0% |